Natera, Inc. today announced that it will release results for its first quarter ended March 31, 2022, after the market close on May 5, 2022.
| AUSTIN, Texas, May 2, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its first quarter ended March 31, 2022, after the market close on May 5, 2022. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities and financial outlook.
Earnings Conference Call Information:
A webcast replay will be available at investor.natera.com. About Natera Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com. Contacts Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350 Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com
SOURCE Natera, Inc. | ||||||||||||||||
Company Codes: NASDAQ-NMS:NTRA |
View original content to download multimedia:
